Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients Caregivers Providers
Log In Ask a Question
PubMed This is a summary of 21 peer-reviewed journal articles Updated
Urology

Diagnosing Cystinuria: Getting the Right Answer

At a Glance

An accurate cystinuria diagnosis requires a three-step approach: specialized stone analysis using infrared spectroscopy, a 24-hour urine collection to detect elevated COLA amino acids, and genetic testing for SLC3A1 or SLC7A9 mutations to confirm the condition.

Diagnosing cystinuria accurately is the foundation of long-term health. Because this condition is rare, the diagnostic process requires a specific “roadmap” of tests to ensure you aren’t misdiagnosed with more common types of kidney stones [1][2].

The Diagnostic Roadmap

A complete workup for cystinuria should include three main components:

  1. Stone Analysis: This is the “gold standard” for diagnosis [3]. If you pass a stone or have one surgically removed, it must be sent to a lab for infrared spectroscopy (ATR-FTIR) or X-ray diffraction [4][5]. These advanced tests identify the exact chemical “fingerprint” of the stone.
  2. 24-Hour Urine Collection: You will be asked to collect all your urine for 24 hours. The lab will measure the “COLA” amino acids—Cystine, Ornithine, Lysine, and Arginine [6][7]. High levels of these four together are a clear sign of cystinuria.
  3. Genetic Testing: A blood or saliva test can look for mutations in the SLC3A1 and SLC7A9 genes [8][9]. This confirms the diagnosis at the molecular level and helps determine the risk for other family members [10][11].

Avoiding Common Pitfalls

Because cystinuria is rare, it is often confused with common calcium oxalate stones. Here is how to ensure your diagnosis is accurate:

  • The Hounsfield Unit (HU) Clue: When you have a CT scan, the radiologist measures how “dense” a stone is using Hounsfield Units [12]. Pure cystine stones are typically less dense than calcium stones. If a stone has a measurement greater than 1000 HU, it is very unlikely to be pure cystine and may be a calcium-based stone instead [12][13].
  • Mixed Stones: It is possible for a person with cystinuria to form “mixed” stones—a core of cystine covered in a layer of calcium oxalate [14]. If a doctor only analyzes the outer layer, they might miss the underlying cystinuria. This is why analyzing the entire stone is critical.
  • The “Invisible” Stone: While most cystine stones show up on X-rays, they are “faint” (radiolucent) compared to calcium stones. A standard X-ray might miss small cystine stones that a CT scan would easily catch [15][16].

Specialized Imaging: Dual-Energy CT (DECT)

If your medical team is unsure about the stone type, they may use Dual-Energy CT (DECT) [15]. This advanced imaging uses two different X-ray energies to “see” the chemical composition of the stone while it is still inside your body [17]. DECT is much better at distinguishing between cystine, uric acid, and calcium than a standard CT scan [15][16].

Why Precision Matters

Cystinuria requires very different treatment than other stone types. For example, some common medications for calcium stones will not work for cystine stones [18][19]. Confirming the diagnosis through stone analysis and 24-hour urine testing ensures you are following the right path to prevent future stones and protect your kidney health [20][21].

Common questions in this guide

How is a cystine kidney stone diagnosed?
The most accurate way to diagnose cystinuria is through a complete stone analysis. If you pass a stone or have one surgically removed, it should be sent to a lab for infrared spectroscopy or X-ray diffraction to identify its exact chemical makeup.
What is the 24-hour urine test for cystinuria?
This test requires you to collect all of your urine over a full 24-hour period. The lab analyzes the sample to measure the levels of four specific amino acids known as COLA (Cystine, Ornithine, Lysine, and Arginine). High levels of these amino acids indicate cystinuria.
Can standard X-rays detect cystine stones?
Standard X-rays can easily miss cystine stones because they are less dense and appear 'faint' compared to common calcium stones. A CT scan, particularly a Dual-Energy CT (DECT), is much more effective at detecting cystine stones and identifying their chemical composition.
Why do doctors measure Hounsfield Units (HU) for kidney stones?
Hounsfield Units measure the density of a stone on a CT scan. Pure cystine stones are generally less dense than calcium stones. If your stone measures above 1000 HU, it is highly likely to be a calcium-based stone rather than pure cystine.
What genes cause cystinuria?
Cystinuria is caused by inherited mutations in either the SLC3A1 or SLC7A9 genes. A genetic test using a blood or saliva sample can identify these mutations, confirming the diagnosis and helping determine if your family members are at risk.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Was my stone analyzed using infrared spectroscopy or X-ray diffraction, and can I see the report?
  2. 2.What were the specific levels of COLA amino acids in my 24-hour urine test?
  3. 3.If my CT scan shows a Hounsfield Unit (HU) above 1000, does that mean I'm forming calcium stones in addition to cystine stones?
  4. 4.Does my genetic test confirm mutations in SLC3A1 or SLC7A9, and what does that mean for my siblings or children?
  5. 5.Is there a specific plan to monitor my urine pH and 'cystine capacity' to see if my current treatment is working?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (21)
  1. 1

    Cystinuria: clinical practice recommendation.

    Servais A, Thomas K, Dello Strologo L, et al.

    Kidney international 2021; (99(1)):48-58 doi:10.1016/j.kint.2020.06.035.

    PMID: 32918941
  2. 2

    Population genetics analysis of SLC3A1 and SLC7A9 revealed the etiology of cystine stone may be more than what our current genetic knowledge can explain.

    Wu CW, Badreddine J, Chang J, et al.

    Urolithiasis 2023; (51(1)):101 doi:10.1007/s00240-023-01473-z.

    PMID: 37561200
  3. 3

    Novel compound heterozygous pathogenic variants in the SLC3A1 gene in a Chinese family with cystinuria.

    Liu D, Zhao Y, Xue X, et al.

    BMC medical genomics 2023; (16(1)):333 doi:10.1186/s12920-023-01767-6.

    PMID: 38114997
  4. 4

    Attenuated total reflection-Fourier transform infrared spectroscopy (ATR-FTIR) detection as a rapid and convenient screening test for cystinuria.

    Primiano A, Persichilli S, Di Giacinto F, et al.

    Clinica chimica acta; international journal of clinical chemistry 2021; (518()):128-133 doi:10.1016/j.cca.2021.03.017.

    PMID: 33794142
  5. 5

    Infrared vibrational spectroscopy: a rapid and novel diagnostic and monitoring tool for cystinuria.

    Oliver KV, Vilasi A, Maréchal A, et al.

    Scientific reports 2016; (6()):34737 doi:10.1038/srep34737.

    PMID: 27721432
  6. 6

    Cystinuria in Dogs and Cats: What Do We Know after Almost 200 Years?

    Kovaříková S, Maršálek P, Vrbová K

    Animals : an open access journal from MDPI 2021; (11(8)) doi:10.3390/ani11082437.

    PMID: 34438894
  7. 7

    Clinical profile of a Polish cohort of children and young adults with cystinuria.

    Tkaczyk M, Gadomska-Prokop K, Załuska-Leśniewska I, et al.

    Renal failure 2021; (43(1)):62-70 doi:10.1080/0886022X.2020.1860089.

    PMID: 33349102
  8. 8

    Clinical and molecular characterization of cystinuria in a French cohort: relevance of assessing large-scale rearrangements and splicing variants.

    Gaildrat P, Lebbah S, Tebani A, et al.

    Molecular genetics & genomic medicine 2017; (5(4)):373-389 doi:10.1002/mgg3.294.

    PMID: 28717662
  9. 9

    Clinical Characteristics and In Silico Analysis of Cystinuria Caused by a Novel SLC3A1 Mutation.

    Liu L, Xu Z, Guan Y, et al.

    Genes 2022; (13(11)) doi:10.3390/genes13112173.

    PMID: 36421847
  10. 10

    A Case of Cystinuria With Compound Heterozygous Mutations Both in SLC3A1 and SLC7A9 Genes.

    Suh SH, Song SH, Choi HS, et al.

    Electrolyte & blood pressure : E & BP 2025; (23(1)):17-21 doi:10.5049/EBP.2025.23.e2.

    PMID: 40630605
  11. 11

    Analysis of SLC7A9 gene mutations among Jordanian patients with cystinuria.

    Halalsheh OM, Al-Shehabat MA, Al-Ghazo MA, et al.

    Annals of medicine and surgery (2012) 2021; (63()):102182 doi:10.1016/j.amsu.2021.102182.

    PMID: 33680451
  12. 12

    Non-contrast computed tomography characteristics in a large cohort of cystinuria patients.

    Warren H, Poon D, Srinivasan R, et al.

    World journal of urology 2021; (39(7)):2753-2757 doi:10.1007/s00345-020-03509-0.

    PMID: 33169184
  13. 13

    Implementation of a Technique Based on Hounsfield Units and Hounsfield Density to Determine Kidney Stone Composition.

    Rodríguez-Plata IT, Medina-Escobedo M, Basulto-Martínez M, et al.

    Tomography (Ann Arbor, Mich.) 2021; (7(4)):606-613 doi:10.3390/tomography7040051.

    PMID: 34698253
  14. 14

    Clinical and genetic characterization of Chinese pediatric cystine stone patients.

    Shen L, Cong X, Zhang X, et al.

    Journal of pediatric urology 2017; (13(6)):629.e1-629.e5 doi:10.1016/j.jpurol.2017.05.021.

    PMID: 28689648
  15. 15

    In Vivo Analysis of Urinary Stones With Dual-Energy Computed Tomography.

    Erdogan H, Temizoz O, Koplay M, Ozturk B

    Journal of computer assisted tomography 2019; (43(2)):214-219 doi:10.1097/RCT.0000000000000831.

    PMID: 30540620
  16. 16

    The Clinical Impact of Accurate Cystine Calculi Characterization Using Dual-Energy Computed Tomography.

    Haley WE, Ibrahim el-SH, Qu M, et al.

    Case reports in radiology 2015; (2015()):801021 doi:10.1155/2015/801021.

    PMID: 26688770
  17. 17

    Efficacy of single-source rapid kV-switching dual-energy CT for characterization of non-uric acid renal stones: a prospective ex vivo study using anthropomorphic phantom.

    Cannella R, Shahait M, Furlan A, et al.

    Abdominal radiology (New York) 2020; (45(4)):1092-1099 doi:10.1007/s00261-019-02164-3.

    PMID: 31385007
  18. 18

    Cystine Stones: Developments in Minimally Invasive Surgery and Their Impact on Morbidity and Stone Clearance.

    Hughes T, Tzelves L, Somani BK

    Research and reports in urology 2023; (15()):175-185 doi:10.2147/RRU.S381190.

    PMID: 37303487
  19. 19

    Outcomes of Tiopronin and D-Penicillamine Therapy in Pediatric Cystinuria: A Clinical Comparison of Two Cases.

    Schaefer B, Garba A, Wu X

    Reports (MDPI) 2025; (8(3)) doi:10.3390/reports8030163.

    PMID: 40981121
  20. 20

    Pharmacological interventions for the management of cystinuria: a systematic review.

    Bhatt NP, Deshpande AV, Starkey MR

    Journal of nephrology 2024; (37(2)):293-308 doi:10.1007/s40620-023-01795-6.

    PMID: 37957454
  21. 21

    Case-based review of dietary management of cystinuria.

    Ucmak H, Sonmez MG, Guven S

    World journal of urology 2023; (41(5)):1215-1220 doi:10.1007/s00345-022-04263-1.

    PMID: 36565321

This page explains the diagnostic process for cystinuria for educational purposes only. Always consult your urologist or nephrologist to interpret your specific imaging, urine tests, and stone analyses.

Get notified when new evidence is published on Cystinuria.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.